Trial
NCT06381830
Clinical Study of CAR-T Cell Therapy Following ASCT for R/R B-cell Non-Hodgkin's Lymphoma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
The First Affiliated Hospital of Soochow University
Collaborators
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd; Suzhou Hongci Hematology Hospital, Suzhou, China
Condition
Lymphoma, B-Cell
Intervention
Apheresis
Why stopped
The study was terminated due to changes in national policy.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-05